Question 1

Does BNP Paribas Financial Markets own TGTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 860,500 shares of TGTX (TG Therapeutics), worth $47.3M.

Question 2

How many shares of TGTX does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 860,500 shares of TGTX (TG Therapeutics).

Question 3

What is BNP Paribas Financial Markets' TGTX position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' TGTX position is worth $47.3M.

Question 4

Is BNP Paribas Financial Markets buying or selling TGTX?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets reduced its TGTX position by 96,526 shares (-10.1%).

Question 5

When did BNP Paribas Financial Markets first buy TGTX?

Accepted Answer

BNP Paribas Financial Markets already held TGTX in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	860,500	-10.1%	$47.3M	0.0%	$54.94	0
2026-Q1	Increased	957,026	+40.0%	$31.8M	0.0%	$33.22	38
2025-Q4	Increased	683,653	+856.6%	$20.4M	0.0%	$29.81	46
2025-Q3	Decreased	71,464	-9.5%	$2.6M	0.0%	$36.13	0
2025-Q2	Decreased	78,980	-85.7%	$2.8M	0.0%	$35.99	0
2025-Q1	Increased	551,029	+822.8%	$21.7M	0.0%	$39.43	46
2024-Q4	Decreased	59,710	-49.4%	$1.8M	0.0%	$30.10	0
2024-Q3	Decreased	117,985	-17.3%	$2.8M	0.0%	$23.39	0

TGTXShowing 8 of 31 quarters

TGTX
Showing 8 of 31 quarters